2011
Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings?
Bai H, Lannin D, Higgins S, Motwani S, Hafty B, Goyal S, Wilson L, Evans S, Moran M. Breast Conservation Therapy for Ductal Carcinoma In Situ (DCIS): Is there a difference in Clinical-Pathologic Features and Long Term Outcomes in Occult, Mammographically-Detected Disease Compared with DCIS Presenting with Physical Findings? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s245. DOI: 10.1016/j.ijrobp.2011.06.1716.Peer-Reviewed Original Research
2007
Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct Carcinoma) of the Skin
Patel S, Yu J, Decker R, Blitzblau R, Housman D, Wilson L. Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct Carcinoma) of the Skin. International Journal Of Radiation Oncology • Biology • Physics 2007, 69: s755-s756. DOI: 10.1016/j.ijrobp.2007.07.2319.Peer-Reviewed Original Research
2003
Concurrent chemo-radiotherapy with mitomycinc (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trial
Haffty B, Son Y, Wilson L, Cho E, Papac R, Fischer D, Rockwell S, Sartorelli A, Sasaki C, Fischer J. Concurrent chemo-radiotherapy with mitomycinc (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trial. International Journal Of Radiation Oncology • Biology • Physics 2003, 57: s246. DOI: 10.1016/s0360-3016(03)01076-9.Peer-Reviewed Original Research
2002
Evaluation of Second Malignancy and Local Recurrence in Patients with T1 and T2 Squamo Cell Carcinoma (SCC) of the Larynx
Colasanto J, Wilson L, Haffty B. Evaluation of Second Malignancy and Local Recurrence in Patients with T1 and T2 Squamo Cell Carcinoma (SCC) of the Larynx. The Cancer Journal 2002, 8: 491. DOI: 10.1097/00130404-200211000-00035.Peer-Reviewed Original Research
1996
2110 Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck
Haffty B, Son Y, Papac R, Fischer D, Wilson L, Rockwell S, Sartorelli A, Sasaki C, Fischer J. 2110 Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck. International Journal Of Radiation Oncology • Biology • Physics 1996, 36: 331. DOI: 10.1016/s0360-3016(97)85686-6.Peer-Reviewed Original Research
1995
Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam Radiation
Licata A, Wilson L, Braverman I, Feldman A, Kacinski B. Malignant Melanoma and Other Second Cutaneous Malignancies in Cutaneous T-Cell Lymphoma: The Influence of Additional Therapy After Total Skin Electron Beam Radiation. JAMA Dermatology 1995, 131: 432-435. DOI: 10.1001/archderm.1995.01690160060009.Peer-Reviewed Original ResearchTotal skin electron beam therapyCutaneous T-cell lymphomaT-cell lymphomaSquamous cell carcinomaBasal cell carcinomaElectron beam therapyAdditional radiation therapyCell carcinomaCutaneous malignanciesOral psoralenAdditional therapyMalignant melanomaRadiation therapyBeam therapyTotal skin electron beam radiationFurther radiation therapyGroup of patientsNonmelanoma skin cancerAnecdotal case reportsPrevious large studiesTopical mechlorethamineHydrochloride therapyCase reportPatientsCarcinoma